Introduction:
A new strain of coronavirus named severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, Hubei
province, China, in December 2019. Since then, the virus spread all over
the world rapidly and became the reason for millions of deaths in the
world. The disease caused by SARS-CoV-2 was termed as Coronavirus
Disease 2019 (COVID-19) and was declared a global pandemic by the World
Health Organization on March 11, 2020 [1]. Severe COVID-19 patients
suffer from severe critical illness with pneumonia, acute respiratory
distress syndrome (ARDS), and multiorgan failure [2]. This novel
coronavirus disease had a dangerous impact on patients, families,
healthcare systems, and communities due to the lack of accurate medicine
and vaccines, especially in the year 2020 and 2021. To decrease the
transmission of the virus, a heavy lockdown was implemented in almost
all the nations of the world and global economic activities were in
turmoil.
The SARS-CoV-2 virus spreads from person to person through small
respiratory droplets and mutates over time. There are several variants
of SARS-CoV-2 developed from several mutations. Alpha, Beta, Gamma,
Delta, and Omicron variants are remarkable variants of SARS-CoV-2. The
Delta (B.1.617.2) variant first emerged in India at a time of low
vaccine coverage and was the most dangerous among all the variants of
the globe due to high transmissibility, the severity of illness, and
death rate [3]. In May 2021, the delta variant of SARS-CoV-2 was the
most dominant variant in maximum countries of the world [6]. The
poor recovery of COVID-19 patients suffering from heart failure,
diabetes, hypertension, malignancy, and chronic kidney disease has been
reported [5]. In this case report, we will discuss how the patient
recovered from severe COVID-19 symptoms after about six months’ rest and
treatment.